PRUEBA PARA LA DETERMINACIÓN DE LA INMUNOGLOBULINA M (IGM)
Mexico·Clase I·III. Agentes de diagnóstico·KABLA COMERCIAL,
S.A. DE C.V.·Registered December 08, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- OMLIPO® IGM KIT (IMMUNOGLOBULIN M)
- Trade Name (English)
- OMLIPO® IGM KIT (IMMUNOGLOBULIN M)
- Analysis ID
- 1545R2022 SSA
- Registration Date
- December 08, 2022
- Name (Spanish)
- KABLA COMERCIAL, S.A. DE C.V.
- Name (English)
- KABLA COMERCIAL, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA PARA LA DETERMINACIÓN DE LA INMUNOGLOBULINA M (IGM) (PRUEBA PARA LA DETERMINACIÓN DE LA INMUNOGLOBULINA M (IGM)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1545R2022 SSA and manufactured by KABLA COMERCIAL, S.A. DE C.V.. The device was registered on December 08, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.